Barclays
RDUS

Barclays’s Radius Health, Inc. RDUS Stock Holding History

Barclays’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,000
Closed -$91K – 6446
2020
Q1 		$91K Sell
7,000
-16,600
-70% -$296K ﹤0.01% 4870
2019
Q4 		$476K Sell
23,600
-20,500
-46% -$498K ﹤0.01% 4351
2019
Q3 		$1.14M Sell
44,100
-4,000
-8% -$98K ﹤0.01% 3542
2019
Q2 		$1.17M Buy
48,100
+40,600
+541% +$887K ﹤0.01% 3524
2019
Q1 		$150K Sell
7,500
-50,100
-87% -$914K ﹤0.01% 5051
2018
Q4 		$950K Buy
57,600
+12,400
+27% +$209K ﹤0.01% 3167
2018
Q3 		$805K Sell
45,200
-2,200
-5% -$49.8K ﹤0.01% 3842
2018
Q2 		$1.4M Sell
47,400
-3,700
-7% -$117K ﹤0.01% 2920
2018
Q1 		$1.84M Sell
51,100
-32,200
-39% -$1.16M ﹤0.01% 2544
2017
Q4 		$2.65M Sell
83,300
-11,000
-12% -$345K ﹤0.01% 2185
2017
Q3 		$3.63M Buy
94,300
+83,300
+757% +$3.27M ﹤0.01% 1791
2017
Q2 		$498K Buy
11,000
+9,100
+479% +$348K ﹤0.01% 3536
2017
Q1 		$73K Buy
1,900
+1,100
+138% +$46.1K ﹤0.01% 5105
2016
Q4 		$30K Buy
+800
New +$38.1K ﹤0.01% 5437

Other funds holding RDUS

RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Barclays's RDUS Position: Q3 2022 in Review

Barclays sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 113,245 shares — an estimated $1.17M sold.

Barclays first reported a position in RDUS in Q4 2014 and held it in 31 quarters. The position peaked at $2.9M in Q3 2019. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • Barclays reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 113,245 Radius Health, Inc. shares in Q3 2022, an estimated $1.17M.
  • Barclays first reported a position in Radius Health, Inc. in Q4 2014 and held it in 31 quarters.
  • Barclays's Radius Health, Inc. position peaked at $2.9M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.